US Stock MarketDetailed Quotes

ImageneBio (IMA)

Watchlist
  • 5.620
  • +0.110+2.00%
Close Aug 24 16:00 ET
  • 5.561
  • -0.059-1.05%
Post 17:18 ET
63.80MMarket Cap-1.20P/E (TTM)

ImageneBio (IMA) Income Statement

Quarterly·All
YOY yoy
Hide blank lines yoy
Currency: USD
2026/Q2
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
Total Revenue as Reported
--0.00
-100.00%0.00
--0.00
-100.00%0.00
--0.00
--800.00K
--0.00
--3.50M
Total Operating Revenue
--0.00
-100.00%0.00
--0.00
-100.00%0.00
--0.00
--800.00K
--0.00
--3.50M
Operating Expense
+60.15%11.78M
+77.76%12.08M
+38.46%8.50M
+380.38%26.59M
--7.36M
--6.80M
--6.14M
--5.54M
Selling and Admin Expenses
+200.00%5.12M
+122.07%6.12M
+119.47%5.23M
+568.44%11.04M
--1.71M
--2.76M
--2.38M
--1.65M
-General & Admin Expense
+200.00%5.12M
+122.07%6.12M
+119.47%5.23M
+568.44%11.04M
--1.71M
--2.76M
--2.38M
--1.65M
Research & Development
+17.97%6.67M
+47.55%5.96M
-12.90%3.27M
+300.46%15.56M
--5.65M
--4.04M
--3.76M
--3.89M
Operating Profit
-60.15%-11.78M
-101.48%-12.08M
-38.46%-8.50M
-1206.19%-26.59M
---7.36M
---6.00M
---6.14M
---2.04M
Net Non-Operating Interest Income (Expense)
+628.81%1.25M
+1566.23%1.13M
+8046.67%2.44M
-308.70%-96.00K
---236.00K
---77.00K
--30.00K
--46.00K
Total Other Finance Costs
-628.81%-1.25M
-1566.23%-1.13M
-8046.67%-2.44M
+308.70%96.00K
--236.00K
--77.00K
---30.00K
---46.00K
Other Income (Expense)
+4055.56%374.00K
+6920.00%341.00K
-185.61%-1.12M
+253.98%1.84M
--9.00K
---5.00K
--1.31M
---1.19M
Other Non-Operating Income (Expenses)
+4055.56%374.00K
+6920.00%341.00K
-185.61%-1.12M
+253.98%1.84M
--9.00K
---5.00K
--1.31M
---1.19M
Pretax Profit
-33.97%-10.16M
-74.58%-10.61M
-49.70%-7.18M
-680.80%-24.85M
---7.59M
---6.08M
---4.80M
---3.18M
Tax
--16.00K
--10.00K
-2223.08%-276.00K
---74.00K
--0.00
--0.00
--13.00K
--0.00
Net Profit
-34.19%-10.18M
-74.74%-10.62M
-43.56%-6.91M
-678.48%-24.78M
---7.59M
---6.08M
---4.81M
---3.18M
Profit from Continuing Operations
-34.19%-10.18M
-74.74%-10.62M
-43.56%-6.91M
-678.48%-24.78M
---7.59M
---6.08M
---4.81M
---3.18M
Net Income to Parent Company
-34.19%-10.18M
-74.74%-10.62M
-43.56%-6.91M
-678.48%-24.78M
---7.59M
---6.08M
---4.81M
---3.18M
Other Preferred Stock Dividends
-100.00%0.00
-100.00%0.00
-100.00%0.00
-71.78%846.00K
--3.15M
--3.05M
--3.06M
--3.00M
Net Income to Common Stockholders
+5.18%-10.18M
-16.33%-10.62M
+12.23%-6.91M
-314.58%-25.63M
---10.73M
---9.13M
---7.87M
---6.18M
Basic EPS
+34.37%-0.63
-16.37%-0.95
+12.23%-0.62
-426.43%-2.91
---0.96
---0.82
---0.70
---0.55
Diluted EPS
+34.37%-0.63
-16.37%-0.95
+12.23%-0.62
-426.43%-2.91
---0.96
---0.82
---0.70
---0.55
Deadline
Jun 30, 2026
Mar 31, 2026
Dec 31, 2025
Sep 30, 2025
Jun 30, 2025
Mar 31, 2025
Dec 31, 2024
Sep 30, 2024
Accounting Standard
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
2026/Q22026/Q12025/Q42025/Q32025/Q22025/Q12024/Q42024/Q3
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On August 24 (U.S. Eastern Time), U.S. Treasury Secretary Bessent announced "unprecedented" economic actions against Iran, aiming to sever i Show More